PROJECT SUMMARY

MENTEBREX is a pre-commercial liquid dietary supplement project of NINROW ISAI DE LEN GARCIA LLC, incorporated in Virginia, United States, on October 25, 2025. I am the owner and active founder, Ninrow Isai de Leon Garcia. I have spent three years studying and documenting the idea and now have physical samples. I am seeking a regular, non-repayable, equity-free grant for a first independent characterization step. This is a commercial LLC, not a nonprofit. I request Manifund's review of whether this proposed work qualifies for charitable funding before any grant is accepted or paid.

GOALS AND APPROACH

The immediate goal is to obtain measured starting-point information about the base 10 mL formulation before further product development. First, reconcile sample identity, preparation and handling requirements with a qualified laboratory. Next, obtain an itemized all-in quote and commission only an affordable, scientifically useful subset of characterization. The proposed first measurements are pH, density and appearance. The broader development plan includes composition, microbiological quality and stability work, but those activities are not all covered by this microgrant. The longer-term intended use is cognitive wellness; no therapeutic outcome or clinical efficacy is established.

SUCCESS CRITERIA

Success for this small step means a laboratory report identifying the sample and methods, reporting the agreed measurements, and a documented decision about the next development step. Positive-looking initial results would not establish safety, shelf life or efficacy. An unfavorable or inconclusive result would also be useful evidence for revising or stopping the current approach. A non-confidential summary of methods, measurements and limitations could provide public value; proprietary formulas are not included in this proposal. Any publication obligations would need to be agreed before funding.

USE OF FUNDS

Minimum request: $500. Maximum request: $1,000. Published-price planning estimates for pH ($185), density ($175) and appearance ($85) total $445. At the minimum, the remaining $55 is a shipping/handling allowance, not a supplier quote. At the maximum, the additional $500 would cover quoted sample logistics or further independently quoted characterization, with the exact allocation agreed before commissioning. No clinical trial, human dosing or efficacy testing is proposed. If the all-in cost is higher, narrow the scope to an affordable useful step rather than assume additional personal spending. The separate 12-month Phase 1 plan is $50,000; this request covers only an initial step, not that entire plan. No expense will be charged twice to different grants.

TEAM AND TRACK RECORD

I am the sole active founder. My documented progress includes three years of self-directed study, formulation documentation, physical samples, US company incorporation and a staged development budget. No laboratory, clinical investigator or additional employee is presented as already engaged. I currently live in Indonesia; the company is legally established in the United States. Public project background: https://solve.mit.edu/solutions/118854 . That listing is not an endorsement or scientific validation.

RISKS AND FAILURE

A laboratory may decline the samples, require further sample information, or quote more than the available grant. Measurements may show variability or fail to resolve the most important questions. The response would be to revise the scope, sample preparation or next-step decision with the laboratory, not to make unsupported product claims. The company's commercial interest may also mean the proposal is outside Manifund's charitable funding scope; please assess that directly. I seek no investment, token arrangement, debt or IP transfer.

OTHER FUNDING

Several grant applications are pending. No award has been confirmed in the current application record. A complete historical total of external funding raised in the last twelve months has not been verified for this proposal, so I do not assert that it is zero. I can supply a reconciled funding history before any award decision.

DRAFTING DISCLOSURE

AI assistance was used to organize the founder-supplied facts and project documents into this proposal.